Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Investigation in the cannabigerol derivative VCE-003.2 as a disease- modifying agent in a mouse model of experimental synucleinopathy


ABSTRACT: Here we explore the striatum transcriptomic effects of alpha-synuclein administration in mice as model of Parkinson´s disease. Moreover, we also explore the neuroprotective effect of cannabonoid-based druga (VCE-003.2) as a potential neuroportective agent in Parkinson´s disease

INSTRUMENT(S): Illumina HiSeq 2000

ORGANISM(S): Mus musculus

SUBMITTER:  

PROVIDER: E-MTAB-13768 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP157201

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2019-11-12 | PXD010845 | Pride
2013-09-20 | E-GEOD-50156 | biostudies-arrayexpress
2014-06-30 | E-GEOD-57530 | biostudies-arrayexpress
2023-07-01 | E-MTAB-11935 | biostudies-arrayexpress
2023-06-29 | E-MTAB-11293 | biostudies-arrayexpress
2014-06-30 | E-GEOD-57531 | biostudies-arrayexpress
2021-09-09 | PXD020642 | Pride
2023-05-22 | E-MTAB-10123 | biostudies-arrayexpress
2014-12-04 | E-MTAB-4131 | biostudies-arrayexpress
2017-10-01 | E-MTAB-5618 | biostudies-arrayexpress